共 381 条
[1]
Ghimire S(2017)Pathophysiology of GvHD and other HSCT-related major complications Front Immunol 8 79-762
[2]
Weber D(2006)Rituximab for steroid-refractory chronic graft-versus-host disease Blood 108 756-101
[3]
Mavin E(2010)Pathogenesis and management of graft-versus-host disease Immunol Allergy Clin N Am 30 75-233
[4]
Wang XN(2003)Chronic graft-versus-host disease Biol Blood Marrow Transplant 9 215-2579
[5]
Dickinson AM(2017)Pathophysiology of chronic graft-versus-host disease and therapeutic targets N Engl J Med 377 2565-414
[6]
Holler E(2002)Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse Blood 100 406-39
[7]
Cutler C(2003)Polymyositis as a manifestation of chronic graft-versus-host disease Rheumatology (Oxford) 42 34-956
[8]
Miklos D(2005)National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report Biol Blood Marrow Transplan 11 945-401.e1
[9]
Kim HT(2015)National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report Biol Blood Marrow Transplant 21 389-1052
[10]
Treister N(2014)Chronic GVHD Consortium. Assessment of joint and fascia manifestations in chronic graft-versus-host disease Arthritis Rheum 66 1044-2341